Qualitative 90-Minute Test Enables Early HIV Detection in High-Risk and Paediatric Patients

Qualitative 90-Minute Test Enables Early HIV Detection in High-Risk and Paediatric Patients – MM1505

Cepheid and FIND announced last month that Xpert® HIV-1 Qual, a qualitative 90-minute molecular HIV test, has achieved CE-IVD status under the European Directive on In Vitro Diagnostic Medical Devices. The test runs on the Cepheid GeneXpert® System, the world’s leading molecular diagnostic platform with over 8000 systems deployed globally in both developed and emerging market countries.

Modern Medicine – May 2015